From candidate to default: the company has just been placed inside buyers' own purchasing systems
The model's full reasoning — Q2 2022 call → NOWe need to determine if the transcript describes the company recently crossing from being a candidate to being an approved/specified/listed/qualified/etc. inside buyers' systems, such that future business can arrive without a discrete selling event, and that this status is new enough that most volume is still ahead. Let's scan the transcript for such descriptions. The call covers various segments: Urban Solutions, Mining & Metals, Advanced Technologies, Mission Solutions, Energy Solutions, NuScale, etc. Key points: - New awards, book-to-burn, margins, etc. - For NuScale: "the NRC voted unanimously to approve the design certification of the new scale SMR." This is a regulatory approval that allows the design to be used. That could be a gateway: being certified by the NRC means the design is approved for use in the U.S. That is a form of being "approved" or "specified" in a regulatory sense. But does that mean buyers will automatically purchase? It's a design certification, not a listing in a procurement system. However, it does mean that the design is approved for use, which could be a prerequisite for utilities to order. But is that a "buyer-side system"? The NRC certification is a regulatory approval, not a purchasing pathway. The question asks about "approved, specified, listed, qualified, registered, reimbursed, or pre-authorized choice inside buyers' own purchasing, reimbursement, formulary, specification, procurement, network, catalog, or program systems." The NRC certification is a government regulatory approval, not a buyer's system. But it could be considered a specification or standard? The transcript says: "the NRC voted unanimously to approve the design certification of the new scale SMR. This follows the standard design approval and issuance of the final safety evaluation report in August 2020. NRC design will now become only the seventh reactor design certification that the NRC has issued for use in the U.S. and the only SMR design." That is a regulatory milestone. Does management convey that this is recent and that most volume is ahead? Yes, they say it's a significant milestone. But is it a "buyer-side system"? The NRC certification is a prerequisite for utilities to order, but it's not a purchasing program.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| WRBY | Warby Parker Inc. | Q1 2024 | 2024-05-09 | A |
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| DXCM | DexCom, Inc. | Q4 2023 | 2024-02-08 | B+ |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| INGN | Inogen, Inc. | Q1 2023 | 2023-05-05 | F |
| HBB | Hamilton Beach Brands Holding Company | Q3 2022 | 2022-11-05 | C |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| MGNI | Magnite, Inc. | Q1 2022 | 2022-05-04 | D |
| AGIO | Agios Pharmaceuticals, Inc. | Q3 2018 | 2018-11-01 | C |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
PRIM · Q2 2018 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, qua...YES The transcript shows management describing exactly this shift for the newly acquired T&D segment: after the Willbros acquisition (closed June 1, 2018), the T&D Group gained access to major utilities that had been hesitant due to prior financial concerns. With Primoris as parent, they signed new awards from the 3 largest electrical utilities (one announced MSA, two not yet announced), allowing work to flow under existing relationships without repeated persuasion. Management explicitly ties this to the recent acquisition and notes the MSA backlog now at $1.1 billion (first time exceeding $1 billion), with one-year estimated MSA revenue at $1.1 billion and continued growth expected.
AGIO · Q3 2018 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, qua...YES The transcript shows management describing exactly this transition for TIBSOVO. Steve Hoerter states that the company launched in July 2018 and is now receiving reimbursement with “no payer-related coverage issues,” with the payer mix (60% Medicare, 35% commercial) reflecting routine placement in those systems. He further notes that initial prescriptions are being written by over 100 unique prescribers and that awareness is already above 90%, confirming the product has moved from candidate status into the reimbursement and purchasing pathways. Because the launch is only a few months old at the time of the call, the $4.
AZEK · Q2 2024 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, etc...YES The transcript shows management describing recent and incremental shelf-space gains in both pro and retail channels as a new development that will support growth in 2025, with investments planned for Q4 to enable these gains. This is framed as moving beyond prior years' steady execution into fresh wins that create a tailwind for future 2025 volume, where the company is now positioned to benefit from expanded availability in buyer systems (catalogs, dealer networks, and retail displays) without needing to re-persuade for each order.